Latest Institutional Placement News

Horizon Minerals has successfully raised $4.65 million through a Share Purchase Plan, supplementing a recent $175 million placement as it advances its Black Swan processing hub development.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Imugene Limited has launched a $20 million capital raising through a $12 million institutional placement and an $8 million Share Purchase Plan, alongside a convertible notes amendment to support its clinical development pipeline.

Bapcor Limited has initiated a fully underwritten $200 million equity raising at $0.60 per share, aiming to reduce debt and support a strategic turnaround under new leadership. The retail entitlement offer opened on 5 March and closes on 19 March 2026.

Investigator Silver Limited has raised A$55 million through an institutional placement to accelerate development of its Paris Silver Project, following a robust feasibility study confirming strong economics and rapid payback.

Magellan Financial Group has successfully raised $130 million through an institutional placement to support its strategic merger with Barrenjoey Capital Partners, with a $20 million share purchase plan also announced for existing shareholders.

Brightstar Resources has successfully upsized its Share Purchase Plan to $18 million, raising total equity proceeds of $193 million to fully fund its Goldfields Project and accelerate development at Sandstone.

Findi Limited has raised A$25 million through an institutional placement to refinance its Indian subsidiary’s balance sheet, reduce debt, and accelerate its ATM rollout and digital payments growth.

Magellan Financial Group has announced a landmark merger with Barrenjoey Capital Partners, creating a diversified financial powerhouse valued at over A$1.6 billion. The deal includes a significant share placement and board reshuffle, setting the stage for expanded market influence.

CONNEQT Health reported a 40% revenue increase to $2.28 million for the half-year ending December 2025, driven by strong sales of its CONNEQT Pulse device and early subscription uptake. Despite narrowing its net loss by 14%, the company continues to navigate operational restructuring and funding challenges as it pivots towards a recurring revenue model.

Radiopharm Theranostics reported a 44% increase in net loss to $27 million for the half-year ended December 2025, driven by expanded R&D spending. The company bolstered its cash reserves through a $35 million placement while progressing multiple clinical trials across its radiopharmaceutical pipeline.

Terra Metals has raised $85 million through an institutional placement to fast-track exploration and development of its promising Southwest Prospect within the Dante Project in Western Australia.